Wisconsin’s biopharmaceutical manufacturing sector is poised for growth

A biohealth hidden gem

For decades, Wisconsin has quietly been an expanding force within the pharmaceutical industry. Now, with the recent announcement that Eli Lilly and Co. will take over a new pharma manufacturing plant, Wisconsin’s star may shine even more brightly.

For decades, Wisconsin companies have been manufacturing the active pharmaceutical ingredients (APIs) that power many kinds of medications sold and used around the world. The trend has escalated in recent years as science and technology have advanced new ways to treat illnesses.

Read the full article here.